Home › Funds › KVP Capital Advisors, LP › CABA

KVP Capital Advisors, LP position in CABA

CABALETTA BIO INC · Health Care

KVP Capital Advisors, LP reported holding 505,431 shares of CABA (CABALETTA BIO INC) in its Q2 2026 13F filing — a position valued at US$1.6M, representing 1.15% of its reported portfolio and ranking #31 among its reported holdings. KVP Capital Advisors, LP has disclosed CABA holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)505.43K sh
Reported value held$1.57M
Portfolio Weight1.15%
First reportedQ4 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How KVP Capital Advisors, LP's CABA position evolved

KVP Capital Advisors, LP first disclosed a stake in CABA in Q4 2025 at 505,431 shares (US$1.1M). The position peaked in Q2 2026 at 505,431 shares, worth US$1.6M. Across 3 filings, KVP Capital Advisors, LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 505,431 shares valued at US$1.6M.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 505.43K $1.11M New
Q1 2026 505.43K $1.36M Hold
Q2 2026 505.43K $1.57M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CABA and 13F data

CABA (CABALETTA BIO INC) is a Health Care company. 38 other funds we track also report a position in CABA — the largest reported positions include Bain Capital Life Sciences Investors, LLC (US$53.6M), Cormorant Asset Management, LP (US$15.6M), Opaleye Management Inc. (US$12.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CABA

All CABA fund holders →

FAQ

How long has KVP Capital Advisors, LP held CABA?

KVP Capital Advisors, LP has disclosed CABA holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is KVP Capital Advisors, LP's current position in CABA?

As of Q2 2026, KVP Capital Advisors, LP holds 505.43K shares of CABA (CABALETTA BIO INC), valued at $1.57M, representing 1.15% of its reported portfolio and ranking #31.

Has KVP Capital Advisors, LP been buying or selling CABA?

In the latest 13F filing (Q2 2026), KVP Capital Advisors, LP held unchanged its position in CABA. The position peaked in Q2 2026 at 505.43K shares.

Which other funds hold CABA?

Other major institutional holders of CABA include Bain Capital Life Sciences Investors, LLC, Cormorant Asset Management, LP, Opaleye Management Inc., among 38 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.